NCT03763006

Brief Summary

The use of povidone iodine solution for prophylaxis of endophthalmitis is well established for intraocular procedures like cataract surgery and for injections of anti-VEGF agents for retinal diseases such as age-related macular degeneration. Unfortunately iodine is unfriendly to the ocular surface, and when repeated often enough (some patients require up to monthly injections of anti-VEGF agents for the entire year), corneal epitheliopathy and secondary dry eye results. Unfortunately, there is no good alternative to cleaning patient's eyelid at the moment. Ocudox is a relatively new antibacterial product (spraying on eyelid wipe) which contains Neutrox (pure hypochlorous acid) that kills many microbes, but remain very friendly and non-toxic for the ocular surface.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
7

participants targeted

Target at below P25 for phase_1

Timeline
Completed

Started Oct 2018

Shorter than P25 for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2018

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

December 3, 2018

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 4, 2018

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2019

Completed
Last Updated

May 13, 2019

Status Verified

December 1, 2018

Enrollment Period

6 months

First QC Date

December 3, 2018

Last Update Submit

May 9, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • SPEED Questionnaire

    To compare the frequency and severity of dry eye symptoms at baseline and after 21 days

    21 days

Study Arms (2)

Ocudox lid wiped

EXPERIMENTAL
Procedure: Eyelid cleaning

Povidone Iodine

ACTIVE COMPARATOR
Procedure: Eyelid cleaning

Interventions

This is a pure hypochlorous acid that kills many microbes, but remain very friendly and non-toxic for the ocular surface.

Ocudox lid wipedPovidone Iodine

Eligibility Criteria

Age50 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Participants must be 50 to 60 years old with Meibomian Gland Dysfunction (MGD)

You may not qualify if:

  • Willing to perform all eye examinations in this study
  • Participants diagnosed with diabetes
  • No recent eye surgery or eye procedure within 1 month
  • Participants who are unsuitable for Oculus K5M recording such as musculoskeletal problems
  • Participants who are unable to tolerate Oculus K5M recording machine
  • Is pregnant, lactating or planning a pregnancy
  • Any other specified reason as determined by clinical investigator

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Singapore Eye Research Institute

Singapore, 169856, Singapore

Location

MeSH Terms

Conditions

Dry Eye Syndromes

Condition Hierarchy (Ancestors)

Lacrimal Apparatus DiseasesEye Diseases

Study Officials

  • Louis Tong, PhD

    Singapore Eye Research Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
Investigator will be masked
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Ocudox lid wipes
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinician-Scientist, Senior Consultant

Study Record Dates

First Submitted

December 3, 2018

First Posted

December 4, 2018

Study Start

October 1, 2018

Primary Completion

April 1, 2019

Study Completion

April 1, 2019

Last Updated

May 13, 2019

Record last verified: 2018-12

Data Sharing

IPD Sharing
Will not share

Locations